ENTPD1 and neoplasm: In the same study emerged that adenosine resulting from circulating human CD39+ Treg and MDSCs, beyond stimulating the vascular endothelial cell proliferation, reduced markedly the migration of effector T cells into the TME, thus disabling the anti-tumor immunity [77,111].